Dedicated to the understanding, treatment, and ultimate cure of substance use disorder by funding cutting-edge research.

Advancing Understanding and Treatment
to Cure of Substance Abuse Disorder

Cure Addiction Now is dedicated to advancing the understanding, treatment, and ultimate cure of substance use disorder (SUD) by funding cutting-edge research and promoting mental health as part of the solution.

Funding research and its clinical translation through a collaborative program is the core focus of the foundation. In addition to creating new therapies to help stop the deadly cycle of SUD, we hope to eliminate the negative stigma of this disease and ultimately find a cure for the brain's "addiction" to drugs.

Cure Addiction Now Members

Funding Cutting-Edge SUD Research

We fund research to understand substance use disorder and develop new therapies. This includes studying brain changes linked to addiction and making detoxification more humane and accessible for those beginning recovery.

Eliminating Negative Stigma

By raising awareness and educating the public, we aim to reduce the stigma surrounding addiction, shift perceptions, and encourage more compassionate treatment of those with SUD.



Promoting Mental Health

We emphasize the importance of mental health as a crucial part of the solution to treating and curing substance abuse disorders. By integrating mental health into treatment and research efforts, our researchers are addressing the underlying psychological aspects that often accompany addiction.

A Mission to Cure SUD

We collaborate with top scientists from top academic institutions to accelerate the development of treatments. By fostering teamwork and sharing research, we’re working toward our goal of curing SUD within our lifetime.

$1.5 Million

Research Funding

20

Doctors

14

Research Experts

40+

Medical Professionals

Cure Addiction Now Founders

Our Founders

Cure Addiction Now is driven by a deep commitment to understanding, treating, and ultimately curing substance use disorder through innovative, cutting-edge research.

Co-founded by Nancy Davis and her late son, Jason Davis, Cure Addiction Now was born from Jason's vision to help others struggling with addiction. Today, we bring together a team of leading doctors and researchers who work tirelessly to develop life-saving treatments. By addressing both addiction and mental health, we aim to break the cycle of addiction and provide real, lasting solutions for both individuals and families in need.

2024 CAN Forum Panelists

Substance Use Disorder (SUD) and Mental Health Research

Cure Addiction Now’s 2024 Fall Forum – Watch Now On September 7, 2024, Cure Addiction Now (CAN) held its semi-annual […]

CAN Forum-Webinar September 2024

Cure Addiction Now Forum Addresses Latest Advances in Substance Abuse Disorder (SUD) Research

Los Angeles, CA (August 2024) – Cure Addiction Now (CAN) will be hosting its semi-annual “CAN Forum & Webinar” at […]

CAN Forum-Webinar September 2024

Cure Addiction Now To Hold Forum & Webinar on Saturday, September 7, 2024

Los Angeles, CA (August 20, 2024) – Following Overdose Awareness Day on August 31 and honoring National Recovery Month in […]


WE CAN MAKE A DIFFERENCE

Join Our Email Newsletter to Stay Informed About Our Educational Events, Research, and News

Cure Addiction Now logo

Testimonials

The public needs to understand that it is a brain disorder. It is a biological problem, it’s not a character flaw. It starts with voluntary use typically. So people think, well just stop - don’t use it. But the substances change the brain and it starts with voluntary use and becomes an uncontrollable compulsion that changes every aspect of the person’s life. Physically, the brain changes.
Dr. Kurt Rasmussen, Ph.D. Scientific Advisory Board Member of Cure Addiction Now & Chief Scientific Officer at Delix Therapeutics
A lot of the work that we've done and part supported by CAN has been able to advance the ways that we measure folks, and measure the treatment outcomes that they have in that period of 1 month, 3 months, 6 months, or a year after they leave treatment.
Dr. Justin Charles Strickland, Ph.D. Johns Hopkins School of Medicine Faculty
Understanding the role genetics plays in drug addiction gives us new therapeutic targets. If we identify a gene that increases the risk of opioid addiction when taking pain medication, we can focus on that gene and the protein it produces. This can help us either prevent addiction or develop targeted therapies. For example, the brain's safety mechanism that tells you to stop harmful behavior deteriorates over time, but our research aims to regenerate those neural circuits.
Dr Barbara Juarez, Ph.D. University of Maryland School of Medicine

Cure Addiction Now Demonstration

Cure Addiction Now Speaker Dr. Justin Charles Strickland, Ph.D.

Cure Addiction Now Panelists